mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |